Full Length Research Paper
References
|
Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK (2013). An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study. Perspect. Clin. Res. 4(4):204-210. |
|
|
Ahn E, Shin DW, Yang H, Yun JM, Chun SH, Suh B, Cho B (2015). Treatment Gap in the National Health-screening Program in Korea: Claim-based Follow-up of Statin Use for Sustained Hypercholesterolemia. J. Korean Med. Sci. 30(9):1266-1272. |
|
|
Almuti K, Rimawi R, Spevack D, Ostfeld RJ (2005) Effects of statins beyond lipid lowering: Potential for clinical benefits. Int. J. Cardiol. 109(1):7-15. |
|
|
Anderson TJ, Gregoire J, Hegele RA, Concutre P, John Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J (2013) 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can. J. Cardiol. 29(2):151-167. |
|
|
Assmann G, Schulte H, Funke H, von Eckardstein A (1998).The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur. Heart J. 19(suppl M):M8-M14. |
|
|
Austin MA, Hokanson JE, Edwards KL (1998). Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81:7B-12B. |
|
|
Bitton A, Choudhry NK, Matlin OS, Swanton K, Shrank WH (2013). The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am. J. Med. 126(4):357-e7 |
|
|
Blenkinsopp A, Anderson C, Armstrong M. (2003). Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk factors for coronary heart disease. J. Public Health Med. 25:144-153. |
|
|
Bluml BM, McKenney JM, Cziraky MJ (2000). Pharmaceutical care services and result in Project Impact: Hyperlipidemia. J. Am. Pharm. Assoc.40:157-65. |
|
|
Bolli P (2014) Treatment of dyslipidemia- the problem of reaching the goal. Atherosclerosis 236(1):142-143 |
|
|
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ (2014) Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 129(3):e28. |
|
|
Hassell K, Eden M (2006). Workforce update – joiners, leavers and practicing and non-practicing pharmacists on the 2005 Register. Pharm. J. Vol. 276. |
|
|
Hoerger T, Bala M, Bray JW, Wilcosky TC, LaRosa J (1998) Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults. Am. J .Cardiol. 82(1):61-65. |
|
|
Ibrahim OM, Hussein1 RN (2017) Knowledge of pharmacists on proper use of oral contraceptive pills and missed dose instructions in United Arab Emirates Trop. J. Pharm. Res. 16(4):947-954 |
|
|
Jahangard-Rafsanjani Z, Sarayani A, Javadi MR., Hadjibabaie M, Rashidian A, Gholami K (2014). Pharmacist's Attitudes and Perceived Barriers about Community Pharmacy-Based Cardiovascular Risk Screening Services. J. Pharm. Care 2(4):142-148. |
|
|
Joyce AW, Sunderland VB, Burrows S, McManus A, Howat P, Maycock B (2007). Community pharmacy's role in promoting healthy behaviors. J. Pharmacy Pract. Res. 37(1):42-44. |
|
|
Keys A, Menotti A, Aravanis C, Blackburn H, Djordjevic BS, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Kimura N, Mohacek I, Nedeljkovic S, Puddu V, Punsar S, Taylor HL, Conti S, Kromhout D, Toshima H (1984). The Seven Countries Study: 2,289 deaths in 15 years. Prev. Med. 13(2):141-54. |
|
|
Khan TM, Azhar S (2013). A study investigating the community pharmacist knowledge about the appropriate use of inhaler, Eastern Region AlAhsa, Saudi Arabia. Saudi Pharm. J. 21(2):153-157. |
|
|
Lee J, Matthew H, Damon B, Ines K, Gerald FW (2013). An audit of pharmacists' knowledge of familial hypercholesterolemia: Implications for community healthcare. Australian Pharm. 32(7):73-75. |
|
|
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ (2015a) – Heart Disease and Stroke Statistics – 2015 Update – A report from the American Heart Association. Circulation 2015, 131(4):e29-322. |
|
|
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ (2015b). Erratum for Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Circulation. 2015 Jun 16; 131(24):e535. Available at: |
|
|
NCEP (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation. 106:3143, Available at: |
|
|
Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA (2011) Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. (Millwood). 30(1):91-99. |
|
|
Stamler J, Wentworth D, Neaton JD (1986). Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA; 256(20):2823-2828. |
|
|
Toth PP (2005). The 'good cholesterol': high-density lipoprotein. Circulation, 111(5):e89-e91. |
|
|
Wadhera RK, Steen DL, Irfan K, Giugliano RP, Foody JM. (2016) A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality. J. Clin. Lipidol. 10(3):472-489 |
|
|
World Health Organization (WHO) (2015). Fact sheet heart disease risk factors. Available at |
|
|
World Health Organization (WHO) (2014). The top 10 causes of death. Web site. |
|
|
SPSS, S. (2010). 19.0. 0 for Windows Software. SPSS Inc., IBM Company, USA. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
